健康大视野·医学分册2023,Issue(12) :10-11,14.DOI:10.3969/j.issn.1005-0019.2023.12.005

分析替格瑞洛配合急诊PCI治疗急性心肌梗死的效果

辛学印
健康大视野·医学分册2023,Issue(12) :10-11,14.DOI:10.3969/j.issn.1005-0019.2023.12.005

分析替格瑞洛配合急诊PCI治疗急性心肌梗死的效果

辛学印1
扫码查看

作者信息

  • 1. 平原县第一人民医院急诊内科,山东 德州 253100
  • 折叠

摘要

目的:分析替格瑞洛配合急诊PCI治疗急性心肌梗死的价值.方法:研究对象纳取我院急诊科收治的200例急性心肌梗死患者,将其随机划分为参照组(治疗方式采取氯吡格雷+急诊PCI治疗)和观察组(采取替格瑞洛+急诊PCI治疗),各100例.治疗后随访半年,比较两组患者的心肌酶谱情况、炎性因子水平和心血管不良事件发生情况.结果:治疗后两组患者的IL-6、TNF-a等炎性因子水平均有不同程度的降低,且观察组心血管不良事件发生率以及心肌酶水平均明显低于参照组,组间数据比较差异较为显著(P<0.05).结论:替格瑞洛联合急

Abstract

Objective To analyze the value of ticagrelor with emergency PCI in the treatment of acute myocardial infarction. Methods The study subjects enrolled 200 patients with acute myocardial infarction admitted to the emergency department of our hospital, randomly divided into reference group (clopidogrel + emergency PCI) and observation group (ticagrelor + emergency PCI, 100 each). Patients were followed up for six months to compare the myocardial enzyme profile, the levels of inflammatory factors and the occurrence of cardiovascular adverse events between the two groups. Results After treatment, the levels of IL-6, TNF-a and other inflammatory factors were reduced in the two groups, and the incidence of cardiovascular adverse events and myocardial enzyme level in the observation group were significantly lower than that of the reference group, and the difference of data between the groups was significant (P <0.05). Conclusion Ticagrelor and emergency PCI for acute myocardial infarction is effective and beneficial.

关键词

氯吡格雷/替格瑞洛/PCI/急性心肌梗死

Key words

clopidogrel/ticagrelor/PCI/acute myocardial infarction

引用本文复制引用

出版年

2023
健康大视野·医学分册
中国保健协会

健康大视野·医学分册

ISSN:1005-0019
参考文献量19
段落导航相关论文